Paper · 22015496
Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria.
Lagoa R and 4 others. Biochim Biophys Acta, 2011. Cited by 137 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria. Papers, record 22015496. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22015496
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochromes c | Major topic |
| Electron Transport Complex I | Major topic |
| Flavonoids | Major topic |
| Hydrogen Peroxide | Major topic |
| Mitochondria | Major topic |
| Oxidants | Major topic |
| Animals | |
| Antimycin A | |
| Antioxidants | |
| Apigenin | |
| Brain | |
| Catechin | |
| Heart | |
| Kaempferols | |
| Oxidation-Reduction | |
| Oxygen Consumption | |
| Quercetin | |
| Rats | |
| Rats, Wistar | |
| Rotenone | |
| Ubiquinone | |
| Uncoupling Agents |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,936,218 | Flavonoids in cancer pharmacology: molecular mechanisms, tumor microenvironment regulation, and drug resistance. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42936218 | PubMed |
| 42,024,273 | Protective effects of vitamin E and quercetin against MDMA-induced cardiac and hematological dysfunction in male wistar rats. | Pflugers Arch | 2026 | https://conductscience.org/library/papers/42024273 | PubMed |
| 41,155,340 | Application of Modulators of Ca2+-Activated Big-Conductance Potassium Channels Against Cd2+-Induced Cytotoxicity: A Study on Two Rat Cell Lines, PC12 and AS-30D. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155340 | PubMed |
| 40,814,876 | Neuro-protective Potential of Honey: A Narrative Review. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/40814876 | PubMed |
| 40,722,907 | Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40722907 | PubMed |
| 40,333,596 | Editorial on the Themed Issue in Honor of Carlos Gutiérrez Merino: Forty Years of Research Excellence in the Field of Membrane Proteins and Bioenergetics. | Molecules | 2025 | https://conductscience.org/library/papers/40333596 | PubMed |
| 39,456,436 | Chemical Composition and Antioxidant Activity of Six Allium Extracts Using Protein-Based Biomimetic Methods. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39456436 | PubMed |
| 39,221,774 | Nobiletin protects against alcohol-induced mitochondrial dysfunction and liver injury by regulating the hepatic NRF1-TFAM signaling pathway. | Redox Rep | 2024 | https://conductscience.org/library/papers/39221774 | PubMed |
| 38,591,201 | Alleviating Neurodegenerative Diseases Associated with Mitochondrial Defects by Therapeutic Biomolecules. | Curr Top Med Chem | 2024 | https://conductscience.org/library/papers/38591201 | PubMed |
| 38,398,528 | An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid. | Molecules | 2024 | https://conductscience.org/library/papers/38398528 | PubMed |
1 to 10 of 74
See all 74 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22015496
GET https://conductscience.org/api/papers/v1/22015496/cited_by?page=2